The current proposal represents closely integrated basic science, preclinical and clinical investigations of the role of cytokine-inducible nitric oxide synthesis as an effector mechanism during cancer immunotherapy with interleukin-2 (IL-2). Since glutathione appears to be a cofactor for the nitric oxide synthase, the goal of the proposed studies is to develop a better understanding of the interrelationship of glutathione biosynthesis with IL-2 induced macrophage and lymphocyte antitumor mechanisms. In Program 1 we will develop cellular and basic science models to evaluate the role of sulfhydryl compounds, such as glutathione and cysteine in regulating the function of the L-arginine dependent pathway of nitric oxide synthesis. These studies will also focus on developing a better understanding of the effector mechanisms of this pathway on a molecular level. Using the cysteine analogue N-acetyl cysteine (NAC) we hope to increase glutathione synthesis in cells and in vivo, and to increase the activity of the cytokine inducible nitric oxide synthase. Since NAC unexpectedly augmented lymphocyte activation by IL-2, as well as improving therapeutic responses to IL-2 in a subcutaneous murine tumor model, we will also evaluate the effects of this agent on cytotoxic lymphocyte function. In Program 2 we will perform the initial toxicity testing of NAC in high-dose IL-2 treated patients. This agent has already been safely used in patients to counteract drug and heavy metal intoxications. The proposed studies will evaluate the maximum tolerated dose of NAC, as well as the dose limiting toxicity. During this Phase IA trial, we will also evaluate the pharmacokinetics of NAC during IL-2 administration. The effect of NAC on the cytokines that induce NO. synthase, the metabolic intermediates of the L-arginine dependent pathway, as well as on the effector mechanisms of this pathway will be evaluated during the course of the clinical study. This combined program should contribute to a better understanding of the role of nitric oxide as an effector mechanism in IL-2 therapy and its role in IL-2 related toxicity. The long term goal of these studies is increase the effectiveness of IL-2 therapy by modulating the activity L-arginine dependent pathway via cysteine analogues.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project--Cooperative Agreements (U01)
Project #
1U01CA058248-01
Application #
3549954
Study Section
Special Emphasis Panel (SRC (74))
Project Start
1992-09-30
Project End
1995-09-29
Budget Start
1992-09-30
Budget End
1993-09-29
Support Year
1
Fiscal Year
1992
Total Cost
Indirect Cost
Name
University of Utah
Department
Type
Schools of Medicine
DUNS #
City
Salt Lake City
State
UT
Country
United States
Zip Code
84112
Kwon, Oh-Deog; Yim, Chang-Yeol; Jeong, Kyu-Shik et al. (2004) Suppression of cytokine-inducible nitric oxide synthesis during intraperitoneal Meth A tumor growth. J Vet Med Sci 66:357-65
Kwon, Oh-Deog; Yim, Chang-Yeol; Jeong, Kyu-Shik et al. (2004) Suppression of cytokine-inducible nitric oxide synthesis during intraperitoneal meth a tumor growth. J Vet Med Sci 66:357-65
Samlowski, W E; Wiebke, G; McMurry, M et al. (1998) Effects of total parental nutrition (TPN) during high-dose interleukin-2 treatment for metastatic cancer. J Immunother 21:65-74
Granger, D L; Taintor, R R; Boockvar, K S et al. (1996) Measurement of nitrate and nitrite in biological samples using nitrate reductase and Griess reaction. Methods Enzymol 268:142-51
Samlowski, W E; Yim, C Y; McGregor, J R et al. (1995) Effectiveness and toxicity of protracted nitric oxide synthesis inhibition during IL-2 treatment of mice. J Immunother Emphasis Tumor Immunol 18:166-78
Yim, C Y; McGregor, J R; Kwon, O D et al. (1995) Nitric oxide synthesis contributes to IL-2-induced antitumor responses against intraperitoneal Meth A tumor. J Immunol 155:4382-90
Seiler, K P; Vavrin, Z; Eichwald, E et al. (1995) Nitric oxide production during murine Lyme disease: lack of involvement in host resistance or pathology. Infect Immun 63:3886-95
Yim, C Y; Hibbs Jr, J B; McGregor, J R et al. (1994) Use of N-acetyl cysteine to increase intracellular glutathione during the induction of antitumor responses by IL-2. J Immunol 152:5796-805
Bastian, N R; Yim, C Y; Hibbs Jr, J B et al. (1994) Induction of iron-derived EPR signals in murine cancers by nitric oxide. Evidence for multiple intracellular targets. J Biol Chem 269:5127-31
Yim, C Y; Bastian, N R; Smith, J C et al. (1993) Macrophage nitric oxide synthesis delays progression of ultraviolet light-induced murine skin cancers. Cancer Res 53:5507-11